Bernard L. Kasten, Director at ENZO BIOCHEM INC (ENZ), sold 83,707 shares at $4.66 ($335K) on 2016-01-21, disclosed to the SEC on 2016-03-18.
Open-market sale of $335k ENZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.66 | 2,500 | $12K | 3.5% |
| 2 | $4.66 | 2,500 | $12K | 3.5% |
| 3 | $3.47 | 18,651 | $65K | 19.3% |
| 4 | $3.47 | 18,651 | $65K | 19.3% |
| 5 | $4.40 | 9,720 | $43K | 12.8% |
| 6 | $4.40 | 9,720 |
| $43K |
| 12.8% |
| 7 | $4.40 | 1,857 | $8K | 2.4% |
| 8 | $4.39 | 3,100 | $14K | 4.1% |
| 9 | $4.39 | 3,100 | $14K | 4.1% |
| 10 | $4.41 | 6,954 | $31K | 9.2% |
| 11 | $4.41 | 6,954 | $31K | 9.2% |
| Total | $4.00 avg | 83,707 | $335K | 100% |
| Filing → |
| CBLI | BUY | 2010-11-22 | $74K | — | Filing → |